現代中藥集團(01643.HK)2023年除税前溢利降45.1%至6830萬元
格隆匯3月22日丨現代中藥集團(01643.HK)公佈,截至2023年12月31日止年度,集團於2023年度錄得收益約人民幣3.441億元,較截至2022年度減少約人民幣5560萬元或13.9%。收益減少主要是由於政府政策的改變,以致經銷商的訂單減少所致。除税前溢利由2022年度約人民幣1.243億元減少約45.1%至截至2023年度約人民幣6830萬元,乃主要由於政府政策的變化,經銷商的訂單減少;及採購成本增加所致。
集團目前已建立具有88名經銷商組成的分銷網絡,覆蓋中國約40個城市,並由逾37名具有傳統中醫藥行業相關經驗的市場推廣人員提供服務及管理。我們相信在可預見的未來,集團的分銷網絡及經銷商模式將繼續支援業務經營的進一步發展。此外,分銷網絡不僅有助於將業務營運從東北及華南擴張至中國其他地區,亦能讓集團頗為深入及廣泛地滲透東北及華南,而由於集團在東北及華南已建立覆蓋點且其地區人口龐大,當地成為集團之戰略目標。於截至2023年度,中國東北、華北及華南地區的收益貢獻分別約為人民幣1.882億元、人民幣5720萬元及人民幣5630萬元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.